We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+20.77%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$547M
Cap. Flow
-$10.2M
Cap. Flow %
-1%
Top 10 Hldgs %
88.16%
Holding
123
New
24
Increased
19
Reduced
32
Closed
28

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$4.7M
2
ZGNX
Zogenix, Inc.
ZGNX
+$3.17M
3
WNC icon
Wabash National
WNC
+$1.87M
4
SAGE
Sage Therapeutics
SAGE
+$1.75M
5
PRTA icon
Prothena Corp
PRTA
+$1.53M

Top Sells

Rank Stock Value
1
HIMX
Himax Technologies
HIMX
+$4.17M
2
MB
MINDBODY, Inc. Class A Common Stock
MB
+$2.9M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$2.74M
4
AMD icon
Advanced Micro Devices
AMD
+$2.52M
5
MYND
Mynd.ai
MYND
+$2.28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.39%
2 Healthcare 8.29%
3 Technology 2.88%
4 Communication Services 2.01%
5 Consumer Discretionary 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXON
26
Axon Enterprise
AXON
$35.9B
$2.15M 0.21%
81,200
+30,000
+59% +$720K
JOYY
27
JOYY Inc
JOYY
$3.78B
$2.03M 0.2%
17,984
-400
-2% -$40.1K
EVBG
28
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2M 0.2%
67,450
-8,300
-11% -$226K
HIMX
29
CALL
Himax Technologies
HIMX
$2.31B
$1.96M 0.19%
188,500
-1,300,000
-87% -$14.1M
WNC icon
30
Wabash National
WNC
$509M
$1.95M 0.19%
+90,000
New +$1.87M
NVRO
31
DELISTED
NEVRO CORP.
NVRO
$1.88M 0.18%
27,200
-900
-3% -$72K
AMZN icon
32
Amazon
AMZN
$2.68T
$1.87M 0.18%
32,000
-4,000
-11% -$220K
BMY icon
33
Bristol-Myers Squibb
BMY
$130B
$1.84M 0.18%
30,000
– –
GTLS
34
DELISTED
Chart Industries
GTLS
$1.79M 0.18%
38,200
-6,800
-15% -$303K
FPRX
35
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.75M 0.17%
80,000
+30,000
+60% +$965K
BAC icon
36
Bank of America
BAC
$416B
$1.7M 0.17%
57,600
-6,200
-10% -$171K
KRNT icon
37
Kornit Digital
KRNT
$657M
$1.58M 0.15%
98,000
+18,000
+23% +$284K
EDU icon
38
New Oriental
EDU
$8.95B
$1.58M 0.15%
16,800
+600
+4% +$53.3K
TAL icon
39
TAL Education Group
TAL
$6.52B
$1.52M 0.15%
51,100
-4,500
-8% -$137K
AXTI icon
40
AXT Inc
AXTI
$3.78B
$1.5M 0.15%
172,000
+130,000
+310% +$1.19M
CLLS
41
Cellectis
CLLS
$162M
$1.46M 0.14%
+50,000
New +$1.36M
CI icon
42
Cigna
CI
$76.3B
$1.42M 0.14%
7,000
– –
CDNA icon
43
CareDx
CDNA
$2.72B
$1.4M 0.14%
+190,000
New +$1.18M
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
$1.36M 0.13%
20,000
-10,700
-35% -$748K
BFYT
45
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$1.26M 0.12%
50,500
+20,600
+69% +$460K
ZYNE
46
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1.25M 0.12%
100,000
-100,000
-50% -$1.15M
EVH icon
47
Evolent Health
EVH
$423M
$1.23M 0.12%
100,000
+50,000
+100% +$705K
DIN icon
48
Dine Brands
DIN
$343M
$1.19M 0.12%
23,400
-4,100
-15% -$191K
AAPL icon
49
Apple
AAPL
$4.84T
$1.15M 0.11%
27,200
– –
PRTA icon
50
Prothena Corp
PRTA
$428M
$1.13M 0.11%
+30,000
New +$1.53M
1
2
3 4 5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Granite Point Capital Management held 123 positions worth $1.02B, up 115% from $475M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Granite Point Capital Management's Q4 2017 filing shows 24 new, 19 increased, 32 reduced and 28 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M. The largest sale was Himax Technologies, an estimated $4.17M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, up from 65% a quarter earlier, followed by Healthcare and Technology.

  • Granite Point Capital Management's largest Q4 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 40,000 shares worth $5.28M.
  • Granite Point Capital Management added most to Zogenix, Inc. in Q4 2017, an estimated $3.17M increase.
  • Granite Point Capital Management's biggest Q4 2017 reduction was Himax Technologies, cutting an estimated $4.17M.
  • Granite Point Capital Management fully exited MINDBODY, Inc. Class A Common Stock in Q4 2017, selling an estimated $2.9M.
  • Granite Point Capital Management's ten largest holdings make up 88% of its $1.02B portfolio in Q4 2017.
  • Granite Point Capital Management opened 24 new positions and closed 28 in Q4 2017.
  • Granite Point Capital Management's portfolio value rose 115% quarter-over-quarter to $1.02B.

Based on Granite Point Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.